A Repurposed Drug Combination Overcomes Paclitaxel Resistance and Minimizes Toxicity via Dual Metabolic and pH Modulation in Breast Cancer
Background: Paclitaxel (PTX) remains a cornerstone in breast cancer treatment, but its effectiveness is limited by both chemoresistance and significant side effects. A promising strategy to overcome these challenges is to repurpose existing drugs. The present investigation sought to explore the combined anticancer effi...